An API portfolio elevated by Verilege™

Navigate the ever-evolving pharmaceutical market with confidence and peace of mind

In the world of pharmaceuticals, managing the intricacies of regulatory compliance, ensuring ingredient quality, and meeting sustainability targets is a complex task.

Our API portfolio is elevated by Verilege™, a distinct suite of expert services and superior customer care that helps simplify the drug approval process. Driven by continuous improvement, Verilege™ helps you achieve and uphold regulatory and quality compliance, progress towards your sustainability goals, and de-risk your supply chain. The Verilege™ program comes in tiered service levels that adapt to your individual needs. This allows you to focus on what really matters - bringing life-changing and life-saving medicines to market.

Advanced expert services with superior customer care

Verilege™ offers access to a suite of expert services and superior customer care to help pharmaceutical customers enter, navigate, and expand within the pharmaceutical market. 

Ensure quality from start to finish. We deliver consistent, high-quality APIs across our global network through:

  • cGMP-certified facilities adhering to the highest manufacturing standards.
  • Robust quality control processes.
  • ICHQ7 compliance for reliable pharmaceutical-grade active ingredients.
  • Continuous investments, with regular inspections by various authorities. 

Simplify the drug filing process and path to approval with comprehensive regulatory dossiers, best-practice sharing, and customized support.

  • Up-to-date dossiers for global registrations—such as CEPs, US DMFs, Japanese DMFs, and China DMFs—along with access to the API section of marketing authorization approvals worldwide.
  • Standard and customizable statements.
  • Personalized assistance with regulatory submissions and documentation to ensure compliance with ICH, US FDA, EMA, and other regional standards.
  • Regulatory documentation gap assessments and regulatory strategy expertise.

Together, we’re not just advancing patient health—we’re driving sustainable progress. We can help you achieve your sustainability goals, including Scope 3 targets.

  • ISO 14040/44-compliant Life Cycle Assessments (LCAs).
  • Transparent data sharing, including primary data, sustainability targets, and certifications (EcoVadis, SBTi).
  • Proprietary tools, like the Imp’Act Card™ program, provide science-based metrics on the environmental footprint, traceability, and social impact at an ingredient level.
  • Expert support for sustainability questionnaires, emission calculations, and co-developing sustainable solutions.

We ensure access to high-quality APIs via a worldwide network of strategically located production facilities. Assuring delivery against GDP requirements, we help de-risk your supply chain, and support your drug development pipeline.

AW-102541-dsm-f-SEP 2025-Text Image-Outlines

Discover the benefits of APIs elevated by Verilege™

Want to learn more about how Verilege™ can ease your drug approvals process? Download the fact sheet to explore the advantages of our API portfolio supported by a suite of specialized expert services, designed to support your quality, regulatory, sustainability, and supply chain needs.

We go beyond ingredient supply; we are solution finders 

Together, we can develop safe and effective drug formulations that are inspired by patients and designed to elevate health. Learn how we can help advance your next drug innovation.

Professional young industrial factory woman employee working with machine parts putting, checking and testing industrial equipments cables in large Electric electronics wire and cable manufacturing plant factory warehouse

Ready to progress with Verilege™?

Connect with your Account Manager to find the right service level that best suits your needs. If you are new to dsm-firmenich and would like to enquire about Verilege™, contact us below.

Related articles

  • New CBD bioavailability study with CBtru®

    New CBD bioavailability study with CBtru®

    New study confirms CBtru®, a novel CBD drug product intermediate, demonstrates equal bioavailability to leading oil-based CBD drug product.

  • Synthetic vs natural CBD ingredients: The differences and why they matter

    Synthetic vs natural CBD ingredients: The differences and why they matter

    Explore five differences between synthetic and natural CBD APIs to inform your next research and development project.

  • Ask the expert: how can ascorbic acid help mitigate nitrosamine risk in drug products?

    Ask the expert: how can ascorbic acid help mitigate nitrosamine risk in drug products?

    Ascorbic acid, and other nitrite scavengers, have been shown to act as functional excipients in drug products that can reduce nitrosamine formation by blocking nitrosation reactions.

How can we help you?

  • New partnership request

    Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.